Supplements and Featured Publications
Leveraging ctDNA/MRD Testing in Breast Cancer Management
Examining Second-Line Treatment Approaches in R/R Mantle Cell Lymphoma
Exploring the Role of FES-PET/CT in Breast Cancer Management
Exploring MRD Assessment in Lymphoma Management
Experts detail the exploration of minimal residual disease and the integration of ctDNA into lymphoma management.
The Evolving Role of Next-Generation Sequencing in NSCLC Management
Navigating Novel Allogeneic Immunotherapy Approaches in Hematologic Malignancies
Advancing Adjuvant Care: Exploring Oral SERDs in ER+, HER2-Negative Early Breast Cancer
Exploring Bispecific Approaches in Frontline Non-Hodgkin Lymphoma
Navigating TKI Selection in Leukemia Care
Traversing Key Updates in HR+ and Triple-Negative Breast Cancer
Exploring Novel Second- and Third-Line Approaches in Metastatic Colorectal Cancer
Managing LEMS in SCLC and Oncology Care
Navigating Second-Line Treatment in Pediatric Low-Grade Glioma
Experts discuss ongoing research and factors driving treatment selection in second-line pediatric low-grade glioma.
Exploring CELMoDs in Multiple Myeloma Management
Experts discuss ongoing research with CELMoDs in the treatment of patients with multiple myeloma.
Measuring the Effect of Experimental Approaches in Metastatic TNBC
Breast Cancer Awareness Month: Navigating the Incorporation of ADCs
Experts discuss the evolving role and ongoing research with antibody-drug conjugates in the management of breast cancer.
2025 ESMO Congress: Focus on Breast Cancer
Summarizing Clinical Advances in the Management of MET Exon 14 Skipping Mutated–NSCLC
Summarizing Clinical Advances in the Management of MET Exon 14 Skipping Mutated–NSCLC
Moving the Needle With MEK Inhibition in Pancreatic Cancer
Prostate Cancer Awareness Month: The Evolving Role of Radioligand Therapy
Experts discuss the evolving role of radioligand therapy during Prostate Cancer Awareness Month.
Navigating TKI Selection in Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia
Experts discuss TKI selection in chronic myeloid leukemia and acute lymphoblastic leukemia.
Understanding the Next Generation of KIT Inhibitors in Indolent Systemic Mastocytosis
Navigating Second-Line Treatment Decisions in CLL
Raising Awareness About the Expanding Use of Immunotherapy in Recurrent Endometrial Cancer
Raising Awareness About the Expanding Use of Immunotherapy in Recurrent Endometrial Cancer
2025 Society of Hematologic Oncology Annual Meeting: Focus on GVHD
Navigating Frontline Treatment Decisions in Metastatic Pancreatic Cancer
Factors informing frontline treatment decisions in metastatic pancreatic cancer.
Outlining the Evolving Efficacy and QOL Outcomes Associated With ADT in Prostate Cancer
Outlining the Evolving Efficacy and QOL Outcomes Associated With ADT in Prostate Cancer
Uncovering the Data Driving IB6-Directed ADC Advances in NSCLC
Optimizing and Individualizing Third-Line and Later Therapies for Metastatic CRC
